New Frontiers in Parkinson's Disease: From Genetics to the Clinic | Journal of Neuroscience
Current Therapies in Clinical Trials of Parkinson's Disease: A 2021 Update
Parkinson's disease: Cerevance outlines Phase II/III trial planned for 2023
Mapping the Clinical Trial Landscape in Parkinson's | by Kevin McFarthing | Parkinson's UK | Medium
How genetic testing can help advance clinical trials for Parkinson's disease
What is a Parkinson's clinical trial? - YouTube
Comparable indicators of therapeutic misconception between epilepsy or Parkinson's disease patients between those with clinical trial experience and trial non-participants - Seizure - European Journal of Epilepsy
Parkinson's disease - Hemacure
Clinical Trials 101 – Parkinson Study Group
Clinical Trials In Parkinson's Disease | SpringerLink
Parkinson's Disease: Current and Future Therapeutics and Clinical Trials: 9781107053861: Medicine & Health Science Books @ Amazon.com
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020 - IOS Press
Treatments and symptoms of Parkinson's
Sample size estimation for clinical trials in de novo Parkinson's disease (PD): Results from the Parkinson's Progression Markers Initiative (PPMI) Study - MDS Abstracts
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020 - IOS Press
Clinical Trials of Parkinson's Treatments Robust Despite COVID-19
Clinical Trials 101 - Parkinson's Disease & Clinical Research
Pharmaceuticals | Free Full-Text | Current Therapies in Clinical Trials of Parkinson's Disease: A 2021 Update
Summary of Clinical Trials in Parkinson's Disease Using Viral-Based... | Download Table
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020 - IOS Press
Clinical Trial Highlights | Journal of Parkinson's Disease
